Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 3/20 | 0.43 |
| ▸ | DRD4 | P21917 | 3/20 | 0.43 |
| ▸ | DRD3 | P35462 | 3/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | DRD5 | P21918 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2913672 | 0.98 | DRD1 (0.44) | DRD1DRD4DRD3DRD2DRD5 | |
| Lithium SCHEMBL29926457 | 0.97 | DRD1 (0.43) | DRD1DRD4DRD3DRD2DRD5 | |
| SCHEMBL1669641 | 0.86 | DRD1 (0.43) | DRD1DRD4DRD3DRD2DRD5 | |
| SCHEMBL30915985 | 0.76 | MAOA (0.48) | DRD1DRD4DRD3DRD2DRD5 | |
| SCHEMBL22379866 | 0.75 | DRD1 (0.45) | DRD1DRD4DRD3DRD2DRD5 | |
| SCHEMBL29927269 | 0.74 | — | — | |
| SCHEMBL1528523 | 0.69 | CYP2B6 (0.36) | CYP2C19CYP2B6CYP3A4CYP2C9MAPK1 | |
| SCHEMBL13097997 | 0.69 | HDAC6 (0.30) | — | |
| SCHEMBL25223676 | 0.68 | ASIC3 (0.44) | PRMT5GRIN2BAKR1C3 | |
| SCHEMBL14101064 | 0.68 | HSD17B3 (0.42) | PRMT5GRIN2BAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190211029-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT. (HU) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211029-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | CYP3A5, CYP4B1, AGPS | DRD1 4339/4885DRD4 4335/4885DRD3 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.